<qa>  What is the main reason for the lipid lowering medication to remain stable for 44. Concurrent allowed lipid lowering medication must be stable for 4 weeks before the baseline visit and must remain stable until 12 weeks after vector administration. These include but are not limited to: statins, ezetimibe, bile acid sequestrants, PCSK9 inhibitors, and LDL andor plasma apheresis. Subjects on other lipid-lowering medications are eligible for the study but must wash out of these medications for the pre-specified time period. 